Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-12, Stock:PFE, The news for the past five days is as follows:
2021-11-05: NEWS1: Kellogg, Pfizer, Airbnb: Stocks That Defined the Week.NEWS2: Epidemiologist slams Aaron Rogers comments on COVID-19: 'It actually is a pandemic of the unvaccinated'.NEWS3: Why Moderna Stock Plunged Today.NEWS4: Dow, S&P 500, Nasdaq end at record highs, extending streak of weekly gains on Pfizer pill study, stronger-than-expected jobs report.NEWS5: Travel Stocks Jump on Hope Pfizer Pill Signals New Reopening.NEWS6: Travel Stocks Rally After Pfizer Touts Covid Pill's Effectiveness.NEWS7: U.S. administers 428 mln doses of COVID-19 vaccines - CDC.NEWS8: Moderna Cedes S&P’s Top-Performer Crown After Record Stock Swoon.NEWS9: EXPLAINER-How does Merck's COVID-19 pill compare to Pfizer's?.NEWS10: Why Pfizer's Covid Pill Results Sent Merck, Moderna And Others Plummeting.NEWS11: Why Carnival, Royal Caribbean, and Norwegian Cruise Line Stocks Surged Today.NEWS12: US STOCKS-S&P 500 books record on strong jobs report, Pfizer COVID-19 pill cheer.NEWS13: EMERGING MARKETS-Currencies firm after U.S. jobs data; Brazilian real leads.NEWS14: Pfizer plans on selling its new covid drug for years to come.NEWS15: Why Disney Shares Are Rising.NEWS16: Pfizer Says Covid-19 Pill Is 89% Effective in Preliminary Assessment.NEWS17: Dow Jones Gains 300 Points on Jobs Report, Merck Shares Slammed on Pfizer's COVID Pill Results.NEWS18: ‘It’s very exciting to see pill form treatments’ for COVID-19: Doctor.NEWS19: Travel stocks drive gains across FTSE after Pfizer pill progress.NEWS20: S&P 500 trades in record territory after Pfizer pill study, stronger-than-expected October jobs report.NEWS21: Dow Jones Hits New High As Stocks Rally On Jobs Data; Earnings Fuel Big Moves.NEWS22: QUOTEBOX-What leaders, health experts said about Pfizer's COVID-19 pill.NEWS23: Moderna cites supply-chain ‘complexity’ as COVID-19 vaccine sales come in $1 billion short.NEWS24: US STOCKS-Wall St extends record rally on strong jobs report, Pfizer COVID-19 pill cheer.NEWS25: Wall Street Clinches Records as Jobs Report, Covid Optimism Spurs Bullish Bets.NEWS26: Dow Jones Rallies On Strong Jobs Report; Peloton Crashes 34% On Earnings; Pfizer Surges On Covid-19 Pill.NEWS27: Pfizer Soars After Covid Pill Shows Strong Results in Study.NEWS28: Why BioNTech Stock Is Plunging Today.NEWS29: U.S. has 'secured millions of doses' of Pfizer's promising new COVID antiviral, Biden says.NEWS30: Former FDA Chief Gottlieb: Pandemic May Be Over by Jan. 4.NEWS31: Why Zoom Shares Are Falling.NEWS32: Pfizer to seek authorization of COVID-19 pill ‘as soon as possible’.NEWS33: Nektar (NKTR) Q3 Earnings Top, Pipeline Remains On Track.NEWS34: Nonfarm Payrolls Jump in October.NEWS35: EMERGING MARKETS-Currencies firm after strong U.S. jobs data; Brazil stocks rally 2%.NEWS36: Pfizer’s positive antiviral news raises hopes for a new easy-to-take treatment for COVID-19, and cases start to rise again in California.NEWS37: Huge Jobs Number: 531K, 4.6% Unemployment; Did Pfizer Cure Covid?.NEWS38: US STOCKS-Wall St extends record rally on strong jobs report, Pfizer COVID-19 pill cheer.NEWS39: Dow Jones, Nasdaq Lead Stocks Higher As October Payrolls Trounce Views; Pfizer Covid Treatment Results Trigger Travel Rally.NEWS40: S&P 500 Hits Record High, Nasdaq Soars on Jobs Gains, Pfizer COVID-19 Drug.NEWS41: Dow, S&P 500 and Nasdaq hit all-time highs after stronger-than-expected October jobs report.NEWS42: Here's Why Shares of Moderna, Novavax, and Ocugen Have All Been Extremely Volatile This Week.NEWS43: UK health minister hails "incredible results" from Pfizer's COVID-19 antiviral trial.NEWS44: UPDATE 2-Canada could see 'bumpy ride' as decline in COVID-19 cases slows - official.NEWS45: Pfizer Stock Is Soaring Because Its Covid Antiviral Appears to Work Really, Really Well.NEWS46: US STOCKS-Wall St eyes record open on strong jobs report, Pfizer COVID-19 pill cheer.NEWS47: Pfizer Tops Merck After Covid Pill Cuts Risk Of Hospitalization, Death By 89%.NEWS48: Why Pfizer Gained $32 Billion in Market Capitalization Today.NEWS49: Why Delta Air Lines Shares Are Rising.NEWS50: Why American Airlines Shares Are Rising.NEWS51: Dow Jones, Futures Rise As October Payrolls Trounce Views; Pfizer Covid Treatment Results Trigger Travel Rally.NEWS52: Stock index futures rise, pointing to more Wall Street records as investors await October payrolls.NEWS53: Sanford leads boom in jobs, housing along U.S. 1 corridor as cost of living in Raleigh, Durham soars.NEWS54: Wall St extends record rally on strong jobs report, Pfizer COVID-19 pill cheer.NEWS55: Merck shares slide premarket as Pfizer soars on data from trial of rival COVID-19 antiviral treatment.NEWS56: Stock futures rise, pointing to more Wall Street records as investors await October payrolls.NEWS57: UPDATE 2-Pfizer says antiviral pill cuts risk of severe COVID-19 by 89%.NEWS58: Pfizer shares soar after data finds COVID antiviral reduced risk of death or hospitalization by 89% in high-risk adults.NEWS59: Pfizer says antiviral pill cuts risk of severe COVID-19 by 89%.NEWS60: Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study.NEWS61: How Will FDA Approval of COVID Vaccines in Younger Kids Impact Pfizer?.NEWS62: Is It Too Late to Buy Pfizer Stock?.NEWS63: The Zacks Analyst Blog Highlights: Nucor, Dow, Pfizer, Costco and Lowe's.NEWS64: 3 COVID Pill Stocks That Might Be Game-Changers.NEWS65: Should Principal U.S. MegaCap ETF (USMC) Be on Your Investing Radar?.NEWS66: 10 Stocks to Buy Under $15 According to Canadian Billionaire Prem Watsa.NEWS67: Pfizer Soars, Pelton Plummets, October Jobs Impress, Dow Futures Gain - Stock Market Live.NEWS68: Peloton, DraftKings Slump Premarket; Pfizer, Airbnb Rise.NEWS69: Pfizer Surges on Encouraging Trial Results for Antiviral Covid-19 Pill.NEWS70: Pfizer Stock Soars On 'Game Changing' Data For COVID Antiviral Pill.NEWS71: U.S. Futures Edge Higher; Payrolls, Peloton and Pfizer in Focus.
2021-11-08: NEWS1: U.S. administers 432 mln COVID-19 vaccine doses, 70% adults fully vaccinated- CDC.NEWS2: Why Novavax Stock Jumped Today.NEWS3: IBD/TIPP Poll: Vaccine Holdouts Dig In With Pfizer, Merck Antiviral Pills Looming.NEWS4: Merck Stock Tumbles On Pfizer Rivalry In Covid Antivirals — Is It A Buy Now?.NEWS5: Moderna Takes A Beating On Mounting Vaccine Challenges — Is It A Buy Or A Sell?.NEWS6: Travel 'confidence level' is surging amid COVID-19 vaccinations: Vacasa CEO.NEWS7: Pfizer Stock Gaps Higher On Covid Pill Enthusiasm — Is It A Buy Now?.NEWS8: Coronavirus: Infectious diseases physician details the latest news and therapeutics in pandemic.NEWS9: Merck Ahead Of Pfizer In Talks With Europe For COVID-19 Pills: Reuters.NEWS10: Why BioNTech Stock Is Bouncing Back Today.NEWS11: 5 ETFs Sizzling to Start November.NEWS12: Pfizer (PFE) COVID Pill Shows Strong Efficacy, Stock Rallies.NEWS13: Regeneron’s Covid Drug Could Be an Alternative to Vaccines.NEWS14: COVID testing costs, hospitalization to drop as treatments enter market: Analyst.NEWS15: COVID-19 pill: Pfizer plans to file for authorization by Thanksgiving.NEWS16: More Good Covid Treatment News; Markets Up Again.NEWS17: Merck ahead of Pfizer in EU talks on COVID-19 pills -EU source.NEWS18: Stock Market News for Nov 8, 2021.NEWS19: Regeneron Drug Could Be an Alternative to Covid Vaccines for Immunocompromised.NEWS20: UPDATE 1-Singapore to decide on COVID-19 vaccine for children aged 5 to 11 this month.NEWS21: Three Encouraging News on U.S. Economic Recovery: 5 Top Picks.NEWS22: Do These 2 Numbers From Pfizer Spell Trouble for Moderna?.NEWS23: Travel stocks fall even as US reopens border to UK flights.NEWS24: Pfizer’s Covid Pill Is Shaking Up the Asia Recovery Trade.NEWS25: Investors are betting that Pfizer’s ‘game-changing’ antiviral pill will reduce demand for COVID vaccines.
2021-11-09: NEWS1: Pfizer to apply for COVID vaccine use in Brazil for children 5-11 years.NEWS2: Why Biohaven Pharmaceuticals Stock Crumbled On This Premium Deal With Pfizer.NEWS3: Pfizer, BioNTech Ask FDA to Expand Covid-19 Booster Use to All Adults.NEWS4: U.S. administers 433.2 mln doses of COVID-19 vaccines - CDC.NEWS5: UPDATE 2-Pfizer seeks FDA nod for COVID vaccine boosters for U.S. adults.NEWS6: Pfizer and BioNTech seek backing of COVID-19 booster for those 18 and over, as U.S. deaths continue to average 1,200 a day.NEWS7: Pfizer asks FDA to authorize COVID-19 booster shot for all adults.NEWS8: REFILE-Pfizer, BioNTech again seek U.S. nod for COVID-19 vaccine boosters in all adults.NEWS9: UPDATE 1-Canada authorizes Pfizer COVID vaccine booster for adults.NEWS10: Pfizer Asking FDA To Approve Booster Shots For All Adults.NEWS11: BioNTech stock reverses lower after earnings report, in which profit and revenue beat expectations.NEWS12: Pfizer and BioNTech to seek backing of COVID-19 booster for those 18 and over, as U.S. deaths continue to average 1,200 a day.NEWS13: Pfizer Gains Outside US Rights To Biohaven's Migraine Treatment For $500M.NEWS14: One year from Pfizer vaccine news, some unlikely market outcomes.NEWS15: BioNTech Stock Is Getting a Lift. Earnings Were Strong..NEWS16: UPDATE 2-Pfizer to market Biohaven's migraine drugs overseas.NEWS17: Biohaven's stock slides 15% on deal with Pfizer for its migraine drug.NEWS18: Biohaven, Pfizer enter up to $1.24 billion deal to market migraine drugs.NEWS19: Better COVID Stock: Merck vs. Pfizer.NEWS20: Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States.NEWS21: The Zacks Analyst Blog Highlights: Tesla, Nucor, Gartner, ON Semiconductor and CBRE Group.NEWS22: BioNTech sees up to 17 billion eur in vaccine revenue this year.NEWS23: BioNTech sees up to 17 billion eur in vaccine revenue this year.NEWS24: Merck stock rallies after U.S. plans to buy 1.4 million more COVID-19 pill courses for $1 billion if authorized.NEWS25: Should You Buy Pfizer Stock After the Fantastic COVID-19 Pill News?.NEWS26: UPDATE 1-French health authority advises against Moderna COVID-19 vaccine for under 30s.NEWS27: Three Key Pieces of Evidence Presented at Elizabeth Holmes’s Trial.NEWS28: A Year After Vaccine Jolt, Bet on Value Stocks Disappoints.NEWS29: French health authority advises against Moderna COVID-19 vaccine for under 30s.
2021-11-10: NEWS1: Dr. Sanjay Gupta on combating COVID-19 vaccine misinformation.NEWS2: Nasdaq Leads Stocks Lower, Pfizer, BioNTech Top S&P 500; Affirm Holdings Rebounds In After-hours Trade.NEWS3: Pfizer Seeks Covid Boosters For All; But How Long Is The Opportunity?.NEWS4: U.S. administers 434.5 mln doses of COVID-19 vaccines - CDC.NEWS5: Investing in Pfizer Stock (PFE).NEWS6: U.S. to Ship J&J Shot to Hot Spots; Italy Boosters: Virus Update.NEWS7: Novavax asks for FDA meeting after first global authorization for COVID-19 vaccine: CEO.NEWS8: Biotech Stock Roundup: REGN, MRNA Post Q3 Earnings, SAVA Gains on AD Review Data.NEWS9: Novavax CEO: We aim to complete the FDA filing for our COVID vaccine this year.NEWS10: White House says 900,000 5- to 11-year-olds were vaccinated during first week of eligibility for scaled-down dose.NEWS11: Pfizer asks the FDA to authorize its COVID booster shot for adults.NEWS12: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference.NEWS13: Biohaven (BHVN) Misses on Q3 Earnings, Inks $1.24B Pfizer Deal.NEWS14: UPDATE 2-Germany recommends only Biontech/Pfizer vaccine for under-30s.NEWS15: Germany Recommends Pfizer/BioNTech Vaccine Over Moderna's.NEWS16: GeoVax Labs In-Licenses Development Rights To Multi-Antigenic COVID-19 Vaccine Candidate.NEWS17: 3 Rock-Solid Healthcare Dividend Stocks Now on Sale.NEWS18: Could Pfizer's COVID Pill Be Even Bigger Than Its Vaccine?.NEWS19: CORRECTED-UPDATE 1-Germany recommends only Biontech/Pfizer vaccine for people under 30.NEWS20: Germany recommends only Biontech/Pfizer vaccine for people under 30.NEWS21: Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan.NEWS22: BioNTech SE (BNTX) Q3 2021 Earnings Call Transcript.
2021-11-11: NEWS1: Moderna Stock Falls Back to Earth as Questions Mount.NEWS2: Next Level Benefits CEO: 'Employers are going to need to pay for' COVID-19 testing at work.NEWS3: Moderna Says COVID-19 Vax Associated With Fewer Cases Than Pfizer's, But Higher Inflammatory Heart Conditions.NEWS4: Zipline, Pfizer and BioNTech Collaboration Paves the Way for Automated, On-Demand Delivery of First mRNA COVID-19 Vaccines in Ghana.NEWS5: Drones Ferry Pfizer’s Precious, Deep-Frozen Vaccine to Africa’s Remote Villages.NEWS6: Merck (MRK) Inks $1.2B COVID-19 Pill Supply Deal With Japan.NEWS7: The Zacks Analyst Blog Highlights: Regeneron, Moderna, Cassava Sciences, Biohaven Pharma and Pfizer.NEWS8: How Pfizer Knocked It Out of the Park in Q3.NEWS9: Should an 11-Year-Old Wait to Get the Bigger Covid-19 Vaccine Dose?.NEWS10: Traders Should Be Stopped Out of Biohaven Pharmaceutical.NEWS11: I’ve already had two Covid jabs, but they don’t count in the UK.

Answer: Decrease